Universal Health International Group Holding (HKSE:02211) Moat Score: 0/10 (As of Sep. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02211 Universal Health International Group Holding Ltd HKSE:02211
37 GF Score
Price HK$0.66
GF Value HK$0.29
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Universal Health International Group Holding Moat Score?

Universal Health International Group Holding has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Universal Health International Group Holding has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Universal Health International Group Holding might have No Moat - No discernible moat.

Universal Health International Group Holding  (HKSE:02211) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Universal Health International Group Holding Moat Score Related Terms

HKSE:02211
37GF Score
Universal Health International Group Holding Ltd HKSE:02211
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Universal Health International Group Holding (HKSE:02211) Overvalued in 2026?

Based on GuruFocus' analysis, Universal Health International Group Holding stock appears to be overvalued. The current stock price of HK$0.66 is trading 125.9% above its estimated GF Value™ of HK$0.29. GuruFocus considers Universal Health International Group Holding to be Significantly Overvalued.

Key valuation signals for HKSE:02211:

  • Moat Score: 0
  • GF Value™: HK$0.29 vs. price of HK$0.66 (125.9% above fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the HKSE:02211 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universal Health International Group Holding Business Description

Address No. 14-1, Bei Yi Zhong Road, Tiexi District, Liaoning Province, Shenyang, CHN
Universal Health International Group Holding Ltd distributes and retails pharmaceutical products in Northeast China. The company operates its business through two segments: pharmaceutical retail and Distribution, (including import and export trade) include prescribed drugs, non-prescribed drugs (Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs), traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, blood products, disinfection products, medical equipment, etc. and majority of revnue comes from Distribution segment.
37GF Score

Get the complete analysis for HKSE:02211

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.66
Price
HK$0.29
GF Value